Powered by

-Enanta Pharmaceuticals, Inc. - Toggle SummaryEnanta Pharmaceuticals Announces Data Presentations at the 2018 NASH-TAG Conference

Dec 27, 2017 - ENP Newswire

WATERTOWN - Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a chemistry-driven biotechnology company dedicated to creating and developing small molecule drugs for viral infections and liver diseases, today announced that two presentations on EDP-305, Enanta's FXR agonist for non-alcoholic steatohepatitis (NASH) and primary biliary cholangitis (PBC), will be presented at the NASH-TAG conference January 4-6, 2018 in Park City, Utah.

Data will be presented from Enanta's Phase 1 study of EDP-305 i...